Smith Group Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

Smith Group Asset Management’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,140	Closed	-$440K	–	486
2018 Q4	$440K	Sell	3,140 -100	-3%	-$15.2K	0.02%	196
2018 Q3	$553K	Buy	3,240 +810	+33%	+$136K	0.02%	195
2018 Q2	$422K	Hold	2,430	–	–	0.01%	203
2018 Q1	$280K	Sell	2,430 -2,000	-45%	-$213K	0.01%	226
2017 Q4	$373K	Hold	4,430	–	–	0.01%	220
2017 Q3	$408K	Buy	+4,430	New	+$344K	0.01%	229

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Smith Group Asset Management's LOXO Position: Q1 2019 in Review

Smith Group Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 3,140 shares — an estimated $440K sold.

Smith Group Asset Management first reported a position in LOXO in Q3 2017 and held it in 6 quarters. The position peaked at $553K in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Smith Group Asset Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Smith Group Asset Management sold 3,140 Loxo Oncology, Inc shares in Q1 2019, an estimated $440K.
Smith Group Asset Management first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 6 quarters.
Smith Group Asset Management's Loxo Oncology, Inc position peaked at $553K in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Smith Group Asset Management's 13F filing for Q1 2019, filed 10 May 2019.